UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$850M |
| 2 |
Apple
AAPL
|
+$778M |
| 3 |
Tesla
TSLA
|
+$569M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$351M |
| 5 |
Johnson & Johnson
JNJ
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Meta Platforms (Facebook)
META
|
+$237M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$223M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$217M |
| 5 |
Vertiv
VRT
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.83% |
| 2 | Healthcare | 7.49% |
| 3 | Financials | 7.15% |
| 4 | Consumer Discretionary | 4.92% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
| $5.65M | ﹤0.01% |
79,399
-40,561
| -34% | -$2.84M |
|
2377
Invesco Biotechnology & Genome ETF
PBE
$353M
| $5.64M | ﹤0.01% |
88,775
+3,070
| +4% | +$195K |
|
2378
iShares Global Materials ETF
MXI
$362M
| $5.64M | ﹤0.01% |
71,656
-5,754
| -7% | -$440K |
|
2379
iShares JPMorgan EM High Yield Bond ETF
EMHY
$637M
| $5.63M | ﹤0.01% |
161,014
-51,078
| -24% | -$1.72M |
|
2380
Children's Place
PLCE
$59.8M
| $5.62M | ﹤0.01% |
154,432
+138,212
| +852% | +$5.17M |
|
2381
Texas Roadhouse
TXRH
$13.7B
| $5.62M | ﹤0.01% |
61,827
+55,299
| +847% | +$5.31M |
|
2382
Utz Brands
UTZ
$1.25B
| $5.62M | ﹤0.01% |
354,108
+17,377
| +5% | +$288K |
|
2383
Silicon Laboratories
SLAB
$7.23B
| $5.61M | ﹤0.01% |
41,384
+40,007
| +2,905% | +$5.26M |
|
|
MAXR
2384
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $5.61M | ﹤0.01% |
108,500
| – | – |
|
|
MAXR
2385
PUT
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $5.61M | ﹤0.01% |
108,500
| – | – |
|
2386
Lithia Motors
LAD
$8.26B
| $5.61M | ﹤0.01% |
27,394
-30,941
| -53% | -$6.61M |
|
2387
Rogers Communications
RCI
$18.6B
| $5.6M | ﹤0.01% |
119,640
-426
| -0.4% | -$18.1K |
|
2388
iShares Mortgage Real Estate ETF
REM
$543M
| $5.6M | ﹤0.01% |
246,781
-10,084
| -4% | -$235K |
|
2389
CALL
ResMed
RMD
$30.7B
| $5.6M | ﹤0.01% |
26,901
+19,401
| +259% | +$4.26M |
|
2390
PUT
BP
BP
$107B
| $5.59M | ﹤0.01% |
160,100
+159,000
| +14,455% | +$5.29M |
|
2391
Vanguard Russell 2000 Growth ETF
VTWG
$1.55B
| $5.59M | ﹤0.01% |
35,884
+8,543
| +31% | +$1.36M |
|
2392
FTI Consulting
FCN
$4.18B
| $5.59M | ﹤0.01% |
35,172
+9,594
| +38% | +$1.6M |
|
2393
Sabra Healthcare REIT
SBRA
$5.37B
| $5.58M | ﹤0.01% |
448,702
+148,857
| +50% | +$1.9M |
|
2394
Rhythm Pharmaceuticals
RYTM
$7.96B
| $5.57M | ﹤0.01% |
191,265
+178,630
| +1,414% | +$4.59M |
|
2395
Sixth Street Specialty
TSLX
$1.81B
| $5.57M | ﹤0.01% |
312,836
-32,712
| -9% | -$586K |
|
|
CTIC
2396
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $5.57M | ﹤0.01% |
926,309
+782,053
| +542% | +$4.27M |
|
|
CPE
2397
CALL
DELISTED
Callon Petroleum Company
CPE
| $5.56M | ﹤0.01% |
150,000
| – | – |
|
2398
PUT
Grocery Outlet
GO
$980M
| $5.55M | ﹤0.01% |
190,000
-80,000
| -30% | -$2.51M |
|
2399
Twist Bioscience
TWST
$7.25B
| $5.54M | ﹤0.01% |
232,839
+207,094
| +804% | +$6M |
|
2400
Victory Capital Holdings
VCTR
$6.65B
| $5.54M | ﹤0.01% |
206,610
+194,382
| +1,590% | +$5.46M |
|
Similar funds
UBS Group's Q4 2022 Portfolio in Review
As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.
- UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
- UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
- UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
- UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
- UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
- UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
- UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.